HDFC PHARMA AND HEALTHCARE FUND REGULAR PLAN GROWTH

Thematic • Very High Risk

HDFC PHARMA AND HEALTHCARE FUND REGULAR PLAN GROWTH

Category: Thematic

CRISIL Rating: Very High Risk

Code: HDHPRGR-GR

NAV

₹17.08

0.17 (1.02%)
2026-03-17
Fund Rating

3 ⭐

Fund Information
Fund Size (AUM): 203.08 CR
Fund Strategy: Very High Risk
Expense Ratio: 2.1100%
Fund Manager:
Min Lump Sum: ₹100.00
Min SIP: ₹100.00
ISIN: INF179KC1HL7
Benchmark:
0.00% 3Y annualised
NAV

₹17.08

2026-03-17
Fund Rating

3 ⭐

Fund Size

203.08 CR

Fund Strategy

Very High Risk

₹500 ₹100,000
Total Investment: ₹15,000
Total Value: ₹0
Login to Invest

Login to create portfolios and start investing

Sector Allocation
Top Holdings
Security Name Weight (%)
Sun Pharmaceuticals Industries Ltd 11.68%
Divi's Laboratories Ltd 10.06%
Cipla Ltd 6.87%
Lupin Ltd 5.60%
Glenmark Pharmaceuticals Ltd 5.53%
Ipca Laboratories Ltd 4.47%
Torrent Pharmaceuticals Ltd 3.83%
Krishna Institute of Medical Sciences Ltd 3.71%
Eris Lifesciences Ltd Registered Shs 3.60%
Aster DM Healthcare Ltd Ordinary Shares 3.59%

Fund Rating

3 out of 5

Funds in Same Category

No other funds found in this category.

Other Funds by This AMC

Fund Name Fund Strategy 3Y Returns Rating AUM (Cr)
HDFC FOCUSED FUND - REGULAR PLAN - GROWTH Hybrid 19.16% 5 ⭐ ₹0.03
HDFC FLEXICAP FUND - GROWTH OPTION Flexi Cap 18.12% 5 ⭐ ₹0.10
HDFC ELSS TAX SAVER - GROWTH OPTION ELSS 16.84% 5 ⭐ ₹0.02
HDFC BALANCED ADVANTAGE FUND - REGULAR PLAN - GROWTH Hybrid 14.81% 5 ⭐ ₹0.11
HDFC MULTI-ASSET ALLOCATION FUND - REGULAR PLAN - GROWTH Thematic 14.18% 5 ⭐ ₹0.01
HDFC LIQUID FUND - GROWTH Liquid 6.90% 5 ⭐ ₹0.07
HDFC MID CAP FUND - GROWTH OPTION Mid Cap 22.38% 4 ⭐ ₹0.09
HDFC LARGE CAP FUND - REGULAR PLAN - GROWTH Large Cap 14.00% 4 ⭐ ₹0.04
HDFC EQUITY SAVINGS FUND- GROWTH Hybrid 9.71% 4 ⭐ ₹0.01
HDFC HYBRID DEBT FUND - GROWTH OPTION Bonds 8.50% 4 ⭐ ₹0.00